Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Mullen James C
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   227,563    

Indirect Shares

  75,000      
Direct Value   $29,809,992    

Indirect Value

  $16,870,500      
Total Shares   302,563      
Total Value   $46,680,492      


Biogen Idec Inc
 $21,482,445 Perkinelmer Inc
 $4,976,902 Insulet Corp
 $1,349,728 Editas Medicine, Inc.
 $394,670 Thermo Fisher Scientific
 $1,606,247 Biogen Idec Inc
 $21,482,445 Perkinelmer Inc
 $4,976,902 Insulet Corp
 $1,349,728 Editas Medicine, Inc.
 $394,670 Thermo Fisher Scientific
 $1,606,247
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    1   
    2    

     Stock price went up :

    0   
    0    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   -1.0   
   -2.0   
     Percentage Gain/Loss :
   -18.6%
 -115.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biogen Idec Inc BIIB CEO & President, Direc... 2010-06-08 95,503 2010-06-08 75,000    Premium*  
            Perkinelmer Inc PKI Director 2014-11-14 45,551 2004-04-27 0    Premium*  
            Patheon NV PTHN Chief Executive Office... 2017-08-29 0 2017-08-29 0    Premium*  
            Insulet Corp PODD Director 2018-05-16 7,783 2017-08-09 0    Premium*  
            Editas Medicine, Inc. EDIT CEO, Director 2022-01-03 75,898 2018-05-18 0    Premium*  
            Thermo Fisher Scientific TMO Director 2024-05-22 2,828 2019-05-22 0    Premium*  
* Premium Members only  

Records found :    181         Free Registration Required For Full Results.    Limit: 25

Download
  Page 8 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
EDIT Editas Medicine, Inc. CEO   •       •      –    2021-10-18 4 S $38.03 $525,033 D/D (13,805) 57,673 0 %
EDIT Editas Medicine, Inc. CEO   •       •      –    2021-12-22 4 A $0.00 $0 D/D 36,477 94,150 0 -
EDIT Editas Medicine, Inc. CEO   •       •      –    2022-01-03 4 S $26.95 $491,979 D/D (18,252) 75,898 0 %
TMO Thermo Fisher Scientific Director   •       •      –    2022-05-18 4 A $0.00 $0 D/D 369 2,097 0 -
TMO Thermo Fisher Scientific Director   •       •      –    2023-05-24 4 A $0.00 $0 D/D 392 2,489 0 -
TMO Thermo Fisher Scientific Director   •       •      –    2024-05-22 4 A $0.00 $0 D/D 339 2,828 0 -

  181  Records found
  1   2   3   4   5   6   7   8     
  Page 8 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed